Follow-up at School-age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature Infants
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
Our previous data demonstrated that premature infants treated with inhaled nitric oxide at
birth had improved neurodevelopmental outcomes at two years corrected age. We now wish to
determine whether this benefit continues through school age.